Consumer and Retail

Dis-Chem: my pick in the sector

The Finance Ghost -
Dis-Chem has several growth levers and seems to be pulling all of them, delivering a strong result in FY22.
Pharmaceuticals and Healthcare

Mediclinic doing well in the recovery room

9WZiafUSdRp5seohu8SR -
Mediclinic has provided a trading update for the year ended March 2022. With full results scheduled for release on 25 May, this gives the market a taste of what happened in that period
Pharmaceuticals and Healthcare

Life’s EBITDA margin is a mixed bag

9WZiafUSdRp5seohu8SR -
Life Healthcare has released a voluntary trading update for the six months to March 2022. This covers the first half of the 2022 financial year.
Pharmaceuticals and Healthcare

Ascendis: more info on the businesses for sale

Ascendis Health has given further information on the financial information of the businesses that form part of the proposed disposal plan.